Outpatient Surgery Magazine

Personal Battle - March 2021 - Subscribe to Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://magazine.outpatientsurgery.net/i/1346819

Contents of this Issue

Navigation

Page 6 of 69

Defend with Profend ® nasal decolonization swabs to reduce the risk of SSIs * . References: 1. PDI in vivo Study PDI-0113-CTEV01 2. PDI user acceptance study *Surgical site infections † From 11 acute care facilities with 50 beds 60-second application with Profend ® nasal swabs before surgery kills 99.7% of S. aureus at 10 minutes and 99.9% at 12 hours. 1 More than 90% of healthcare providers surveyed prefer Profend over other PVP-Iodine products because it can be applied up to 2.5x faster— just snap open and use 2† . Profend is clinician-administered for 100% compliance, with a compact design for patient comfort. It's the effi cient, mess-free way to defend against SSIs. * Learn more at www.DefendwithProfend.com BE THE DIFFERENCE ® © 2021 PDI PDI11207194

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - Personal Battle - March 2021 - Subscribe to Outpatient Surgery Magazine